Treatment Patterns by Race and Ethnicity in Newly Diagnosed Persons with Multiple Sclerosis.

Caroline Kelley GeigerDaniel SheinsonTu My ToDavid JonesNicole Gidaya Bonine

Published in: Drugs - real world outcomes (2023)

Use of high-efficacy DMTs was low across all race/ethnicity subgroups of newly diagnosed pwMS in the US, including populations at a greater risk of experiencing rapid disease progression and severe disability.

Keyphrases

newly diagnosed
multiple sclerosis
white matter
loop mediated isothermal amplification
drug induced
quantum dots